Literature DB >> 2143774

T cell receptor-mediated negative selection of autoreactive T lymphocyte precursors occurs after commitment to the CD4 or CD8 lineages.

C J Guidos1, J S Danska, C G Fathman, I L Weissman.   

Abstract

To identify the maturational stage(s) during which T cell receptor (TCR)-mediated positive and negative selection occurs, we followed the development of CD4+8- and CD4-8+ T cells from TCRlo CD4+8+ thymic blasts in the presence of different positive and negative selecting (major histocompatibility complex or Mls) elements. We describe novel lineage-committed transitional intermediates that are TCRmed CD4+8lo or TCRmed CD4lo8+, and that show evidence of having been positively selected. Furthermore, negative selection is not evident until after cells have attained one of the TCRmed transitional phenotypes. Accordingly, we propose that negative selection in normal mice occurs only after TCRlo CD4+8+ precursors have been positively selected into either the CD4 or CD8 lineage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143774      PMCID: PMC2188558          DOI: 10.1084/jem.172.3.835

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  38 in total

1.  The presumptive CDR3 regions of both T cell receptor alpha and beta chains determine T cell specificity for myoglobin peptides.

Authors:  J S Danska; A M Livingstone; V Paragas; T Ishihara; C G Fathman
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

Review 2.  Early events in T-cell maturation.

Authors:  B Adkins; C Mueller; C Y Okada; R A Reichert; I L Weissman; G J Spangrude
Journal:  Annu Rev Immunol       Date:  1987       Impact factor: 28.527

3.  A T cell receptor V beta segment that imparts reactivity to a class II major histocompatibility complex product.

Authors:  J W Kappler; T Wade; J White; E Kushnir; M Blackman; J Bill; N Roehm; P Marrack
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

4.  Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes.

Authors:  R K Saiki; T L Bugawan; G T Horn; K B Mullis; H A Erlich
Journal:  Nature       Date:  1986 Nov 13-19       Impact factor: 49.962

5.  T cell tolerance by clonal elimination in the thymus.

Authors:  J W Kappler; N Roehm; P Marrack
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

6.  Correlation of cell surface antigen expression on human thymocytes by multi-color flow cytometric analysis: implications for differentiation.

Authors:  L L Lanier; J P Allison; J H Phillips
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

7.  A simple and very efficient method for generating cDNA libraries.

Authors:  U Gubler; B J Hoffman
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

8.  The major histocompatibility complex-restricted antigen receptor on T cells: distribution on thymus and peripheral T cells.

Authors:  N Roehm; L Herron; J Cambier; D DiGuisto; K Haskins; J Kappler; P Marrack
Journal:  Cell       Date:  1984-09       Impact factor: 41.582

9.  Thymus cell migration. Quantitative aspects of cellular traffic from the thymus to the periphery in mice.

Authors:  R G Scollay; E C Butcher; I L Weissman
Journal:  Eur J Immunol       Date:  1980-03       Impact factor: 5.532

10.  On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for dual recognition?

Authors:  R M Zinkernagel; G N Callahan; A Althage; S Cooper; P A Klein; J Klein
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  42 in total

Review 1.  The polymerase chain reaction and other amplification techniques in immunological research and diagnosis.

Authors:  A M Lew; R B Brandon; M Panaccio; C J Morrow
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

Review 2.  Are we really on the right TRAIL?

Authors:  Erika Cretney; Adam P Uldrich; Stuart P Berzins; Andreas Strasser; Dale I Godfrey; Mark J Smyth
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

3.  Immature thymocytes are protected from deletion early in ontogeny.

Authors:  T H Finkel; J W Kappler; P C Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

Review 4.  Quantitative challenges in understanding ligand discrimination by alphabeta T cells.

Authors:  Ofer Feinerman; Ronald N Germain; Grégoire Altan-Bonnet
Journal:  Mol Immunol       Date:  2007-09-06       Impact factor: 4.407

5.  Two distinct pathways of positive selection for thymocytes.

Authors:  K Akashi; M Kondo; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

6.  Antibody Conditioning Enables MHC-Mismatched Hematopoietic Stem Cell Transplants and Organ Graft Tolerance.

Authors:  Benson M George; Kevin S Kao; Hye-Sook Kwon; Brenda J Velasco; Jessica Poyser; Angela Chen; Alan C Le; Akanksha Chhabra; Cassandra E Burnett; Devon Cajuste; Malachia Hoover; Kyle M Loh; Judith A Shizuru; Irving L Weissman
Journal:  Cell Stem Cell       Date:  2019-06-13       Impact factor: 24.633

7.  Characterization of T-cell subsets and T-cell receptor subgroups in pigtailed macaques using two- and three-color flow cytometry.

Authors:  I Axberg; M J Gale; B Afar; E A Clark
Journal:  J Clin Immunol       Date:  1991-07       Impact factor: 8.317

8.  Precommitment of CD4+CD8+ thymocytes to either CD4 or CD8 lineages.

Authors:  T Crompton; R K Lees; H Pircher; H R MacDonald
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

9.  Constitutive activation of integrin alpha 4 beta 1 defines a unique stage of human thymocyte development.

Authors:  D R Salomon; C F Mojcik; A C Chang; S Wadsworth; D H Adams; J E Coligan; E M Shevach
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

10.  Differentiation of CD3-4-8- human fetal thymocytes in vivo: characterization of a CD3-4+8- intermediate.

Authors:  D L Kraft; I L Weissman; E K Waller
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.